INTRODUCTION: Panic disorder (PD) is a common anxiety disorder impairing strongly quality of life with high social costs. Effective anti-panic medications exist but a substantial proportion of patients do not fully respond, the available drugs have several side effects and most medications have a delayed onset of their therapeutic effect. Thus, further advances are needed. AREAS COVERED: We review available data on emerging drugs for the treatment of PD including those in development, such as metabotropic glutamate II receptor agonists,
Emerging drugs for panic disorder
Perna G;Caldirola D
2011-01-01
Abstract
INTRODUCTION: Panic disorder (PD) is a common anxiety disorder impairing strongly quality of life with high social costs. Effective anti-panic medications exist but a substantial proportion of patients do not fully respond, the available drugs have several side effects and most medications have a delayed onset of their therapeutic effect. Thus, further advances are needed. AREAS COVERED: We review available data on emerging drugs for the treatment of PD including those in development, such as metabotropic glutamate II receptor agonists,File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
84 emerging drugs 2012.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Copyright dell'editore
Dimensione
287.77 kB
Formato
Adobe PDF
|
287.77 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.